Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal/Phase III Multicentered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 Solution (Zuragen), and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis

NCT00628680 is registered in ClinicalTrials.gov with Ash Access Technology as lead sponsor.

NCT NCT00628680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00628680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal/Phase III Multicentered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 Solution (Zuragen), and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis
Lead sponsor
Ash Access Technology
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2006
Completion date
Not reported
Enrollment
415 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease